Head-to-head · WeighScore
ElleS vs Omada Health
The verdict
ElleS takes it — 56/100 to 55.6/100, but only just.
ElleS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. ElleS (ElleS Inc.) is a comprehensive compounded telehealth service. Omada Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | ElleS | Omada Health |
|---|---|---|
| WeighScore | 56/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #423 | #435 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #423 · C
Strengths
- Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
- Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
- Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
- Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)
Where it loses points
- Pricing not shown publicly — products and costs appear only after the intake flow
- Sold as 3- and 6-month packages rather than simple monthly plans
- Compounding pharmacy partner not named ('made in licensed US facilities')
- Not LegitScript-certified (no certification displayed)
Graded #435 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.